🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchEcnoglutide, mazdutide, and other emerging GLP-1 pipeline agents Page 3

Ecnoglutide, mazdutide, and other emerging GLP-1 pipeline agents

TrialTracker_MD Mon, Mar 9, 2026 at 9:47 AM 19 replies 418 viewsPage 3 of 4
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 9, 2026 at 2:02 PM#11

Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.

Thread quality is excellent — keep it up. 👍

Last edited: Mar 9, 2026 at 6:02 PM
8 22PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 5 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Mar 9, 2026 at 2:19 PM#12

Slightly tangential to Ecnoglutide, mazdutide, but InsuranceTom reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Mar 9, 2026 at 5:19 PM
8 5NurseKim_ATL, paul_denver, TinaHashiRN and 5 others
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Mar 9, 2026 at 2:36 PM#13
LeilaHI said:
Follow-up question: what labs did your doctor order to monitor this

This is exactly right. LeilaHI articulated what I have been trying to explain to my friends for months. The Ecnoglutide, mazdutide, aspect is what made the difference for me.

30 12paul_denver, TinaHashiRN, robert_kc and 27 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Mar 9, 2026 at 2:53 PM#14

Saving this for reference. Quality thread.

Last edited: Mar 9, 2026 at 8:53 PM
32 22sarah_nash92, FitDadDave, RunnerRach and 29 others
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Mar 9, 2026 at 3:10 PM#15

Adding my data to this Ecnoglutide, mazdutide, discussion:

MetricBaselineMonth 5Month 6
Weight240 lbs220 lbs215 lbs
A1C6.4%6.0%5.2%
hsCRP4.04.00.6

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.2g/kg/day.

Last edited: Mar 9, 2026 at 5:10 PM
36 13tampaLisa73, KarenAZ_mom, zoe_NC and 33 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register